Full-Time
Technical Product Manager
Senior
Lyric
201-500 employees
AI-driven payer payment integrity platform
Compensation Overview
$150.3k - $225.4k/yr
Remote in USA
Remote
Bachelor's
 Product (1) |
|---|
Get referred to Lyric
See people who can refer or advise you
- 8+ years of product management experience, with at least 3 years owning technical or platform products.
- 8+ years experience showing a deep understanding of how platform capabilities (e.g., infrastructure, deployment, observability, authentication, APIs) drive product success.
- Bachelors Degree in Engineering or similar technical focus
- Own the product lifecycle for one or more core platform capabilities
- Collaborate cross-functionally with engineering, architecture, and product teams to deeply understand technical needs and business context.
- Drive requirements gathering, documentation, and prioritization for foundational services and systems.
- Translate complex business and technical concepts into clear product narratives and development plans.
- Ensure solutions are scalable, secure, observable, and supportable from day one.
- Define KPIs and success metrics for platform adoption, performance, and efficiency.
- Build alignment across stakeholders, balancing short-term delivery with long-term platform vision.
- 3 + Years Healthcare industry experience
- Demonstrated ability to work across teams and influence without authority in a matrixed environment.
- Excellent communication and storytelling skills; able to tailor messages to both technical and non-technical audiences.
- Strong technical acumen; able to engage with engineers and architects in deep technical discussions.
- Experience working with internal developer platforms or building foundational services used across multiple product teams.
- Proven track record of managing complex initiatives involving multiple stakeholders and technical constraints.
Lyric AI provides analytics-driven health care payer solutions to improve payment integrity and efficiency for health plan payers, built on 30 years of ClaimsXten experience and using AI, machine learning, blockchain, and large language models to detect improper payments. The platform connects to transactional systems once and offers a range of first- and third-party payment integrity checks through a subscription-based model and transaction fees. It differentiates itself with a long track record, deep domain expertise, high customer retention, and substantial client savings of about $12–$14 billion per year, currently serving nine of the top ten payers. The goal is to help payers maximize payment accuracy and integrity, reduce costs, and maintain compliant, efficient payment operations.
Company Size
201-500
Company Stage
Growth Equity (Venture Capital)
Total Funding
$90.9M
Headquarters
Upper Merion Township, Pennsylvania
Founded
2007
Get referred to Lyric
See people who can refer or advise you
Simplify's Take
What believers are saying
- Lyric acquired Concert on July 15, 2026, expanding diagnostics and precision-medicine payment rules.
- Lyric42 added intelligent orchestration on July 17, 2026 for real-time payment sequencing.
- Everest Group named Lyric a 2026 pre-payment integrity Leader alongside Optum and Zelis.
What critics are saying
- Lyric competes with Cotiviti, Gainwell, Machinify, Optum, and Zelis in 2026 leader rankings.
- Payer rule updates at BCBSMT and BCBSTX show customers can swap Lyric edits without notice.
- Concert integration stalls while rivals bundle similar edits into broader claims platforms faster.
What makes Lyric unique
- Lyric42 connects policy, coding, clinical review, and AI through one payer integration.
- ClaimsXten remains embedded at Blue Cross Blue Shield Montana and Texas in 2026.
- Concert acquisition adds machine-readable clinical policy to Lyric's payment accuracy stack.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Hybrid Work Options
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↓ -2%Lyric, a healthcare decision intelligence company, has acquired Concert, a precision health payment accuracy leader. The acquisition combines Concert's proprietary technology for translating machine-readable policies into real-time decisions with Lyric42, Lyric's Healthcare Decision Intelligence Platform. Concert brings over a decade of expertise in building machine-readable clinical policy. The two companies have collaborated since 2023, with their joint solution growing nearly tenfold in scope and impact. The combined platform aims to help health plans manage rising costs and keep pace with rapidly evolving clinical evidence. It delivers policy, data, and decision-making capabilities into existing systems used by health plans and providers. Lyric currently supports 200 million lives, with nine of the top 10 US health plans using its platform.
Lyric acquires Concert to expand AI-enabled precision medicine payments. Concert's platform will be integrated into Lyric42 to enhance healthcare payment accuracy for diagnostic and genetic testing. Payment-focused healthcare intelligence platform Lyric announced its acquisition of precision medicine-focused payment technology company Concert to combine Concert's policy intelligence with the Lyric42 platform. Lyric offers health plans tools that analyze policy, data, AI and clinical review after care and before payment to help identify claims that may be incorrect, duplicate or not compliant with a payer's policies. Concert works with health plans, care providers, laboratories and health technology vendors to help manage diagnostic and precision medicine testing. Its platform combines clinical evidence, medical policies, coding standards, and payment rules to allow diagnostic tests, such as genetic and other laboratory tests, to be ordered, reviewed and reimbursed more accurately. The companies, which have had an established partnership since 2023, said the acquisition will merge Concert's precision medicine capabilities with Lyric's AI-enabled decision intelligence platform. "This combination allows us to accelerate our pace of innovation for our clients," Ravi Umarji, Lyric president and CFO, said in a statement. "Concert's ground-up approach to synchronize human- and machine-readable policy will plug into health plan workflows through the Lyric42 platform. This approach fundamentally shifts the model from reactive enforcement at disconnected checkpoints to shared standards, providing transparency and alignment across stakeholders. The combination will benefit our health plan clients, their network providers and the members they serve." THE LARGER TREND Concert and Lyric initially established a partnership in 2023 to combine machine learning models and market data to improve payment accuracy for genetic testing claims. In 2024, the pair expanded their collaboration to focus on laboratory payment accuracy for advanced and routine tests. Last year, Lyric acquired ClaimShark, a payment technology company for health plans. ClaimShark's offerings were integrated into Lyric's platform, resulting in Lyric having an AI/cloud foundation that connects payers to a library of data analytics, pre-pay editing and overpayment detection tools. That same year, Connect partnered with health information network Availity to digitize and automate prior authorizations for genetic testing. A year before, Concert integrated its coding standards and Genetic Testing Unit (GTU) identifier with EviCore's medical policies and authorization guidelines with the aim of improving authorizations and efficiency of molecular and genomic testing for health plans, providers and patients.
Lyric, a healthcare decision intelligence platform provider, has announced that leading health plans are using advanced orchestration capabilities within its Lyric42 platform to coordinate payment decisions across rules, workflows and payment accuracy products. The intelligent orchestration capabilities help health plans improve payment accuracy by dynamically sequencing and reconciling payment decisions in real time, rather than processing claims through fixed rules. The system draws on policy context, historical outcomes, provider impact and reimbursement risk to generate payment recommendations. Lyric aims to help health plans reduce administrative waste, unnecessary audits and denials whilst lowering costs for both insurers and providers. CEO Halsey Wise said the platform augments human decision-making with better coordination and evidence to enable more confident payment decisions at scale.
Srilakshmi Kesari takes over as VP & India HR head, Lyric.ai. Lyric.ai has appointed Srilakshmi Kesari as its new vice president and country HR head for India, marking a significant addition to the company's leadership team. The AI-driven healthcare technology firm is expanding rapidly, and this appointment signals its focus on strengthening operations in one of its key global hubs. In her new role, Kesari will guide the overall people strategy for the India organisation. Her mandate includes nurturing a strong workplace culture, building a future-ready talent framework, and enhancing employee experiences across the board. The company is looking to deepen its capabilities in artificial intelligence, machine learning, and predictive analytics, and her leadership will be central to developing the skilled workforce needed to support these goals. Prior to this, she was associated with Tata Consultancy Services as its head-HR- talent engagement and development. She joined the company in 2023. Backed by 21 years of experience in strategic HR, Kesari's expertise lies in talent management, talent acquisition, resource management, compensation and benefits and employee relations. She has experience leading the entire gamut of HR in multinational companies as well as GCCs. An alumna of Andhra University, she has proved her excellence in creating and implementing talent- acquisition strategies ranging from university relations through senior executive recruitment. Kesari's appointment comes at a time when the company is accelerating its mission to simplify the business side of care. By strengthening talent practices and shaping a cohesive culture, she is expected to enable teams in India to deliver greater impact and support Lyric.ai's broader vision of building intelligent, reliable and scalable healthcare solutions. With this leadership change, Lyric.ai aims to reinforce its commitment to building a high-performing, people-centric organisation as it continues to grow its global presence.
Lyric, an AI-powered platform, has secured $43.5 million in a Series B funding round led by Insight Partners. The company, based in Sunnyvale, California, addresses the challenges of outdated supply chain software by providing dynamic and flexible solutions. Since emerging from stealth 18 months ago, Lyric has achieved 500% revenue growth and now supports nearly 30 major global enterprises. To date, Lyric has raised a total of $67 million.